SQI Signs Agreement with a Global Biotechnology Company

January 17, 2018

Responsive image

TORONTO, Jan. 17, 2018 /PRNewswire/ – SQI Diagnostics Inc. (“SQI” or the “Company”) (TSX-V: SQD; OTCQB: SQIDF), today announced it has signed a revenue-producing agreement with a global biotechnology company to provide assay development and future sample testing and analysis services….

Category: Precious Metals